Furthermore, exposure of primary CLL cells to nutlin-3, a MDM2 inhibitor, induced both NEAT1 and lincRNA-p21 transcription in a p53-dependent manner. The gene discussed is NEAT1; the disease is B-cell chronic lymphocytic leukemia.